Shareholding for the Period Ended December 31, 2015
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here22-01-2016
22-01-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Bliss GVS Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-01-2016
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Vibha N Kamath has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201106-12-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shruti Vishal Rao has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201126-11-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bliss GVS Pharma Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201126-11-2015
Revised Financial Results for Sept 30, 2015
With reference to the earlier Announcement dated November 09, 2015, regarding Financial Results for Sept 30, 2015, Bliss GVS Pharma Ltd has informed BSE that there is minor typographical error in the unaudited financial results, apparently show "Q2" which should be "half year ended". Now the Company submitted Revised Financial Results for Sept 30, 2015.10-11-2015
Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09, 2015, inter alia, has considered and approved the followings :1. Appointed Dr. Hira Sadhak- Ph.D in Industrial Finance, as Independent Director of the Company;2. Appointed Ms. Aditi Bhatt as the Company Secretary of the Company;3. Ms. Sushama Yadav resigned as the Company Secretary of the Company.09-11-2015
Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Bliss GVS Pharma Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.09-11-2015
Board Intimation for Results & Closure of Trading Window
Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company for the quarter ended September 30, 2015 is scheduled to be held on November 09, 2015, inter alia, to consider the Un-Audited Financial Results of the Company for the quarter ended September 30, 2015.Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair Disclosure of the...28-10-2015
Shareholding Pattern for September 30, 2015
Bliss GVS Pharma Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.21-10-2015